Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?

키워드

참고문헌 (16)

1. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)[DOI]
2. Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology", Gastroenterology, 142, pp.1592~1609 (2012)[DOI]
3. Anstee QM, "Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis", Nat Rev Gastroenterol Hepatol, 10, pp.330~344 (2013)[DOI]
4. Bugianesi E, "Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma", Gastroenterology, 123, pp.134~140 (2002)[DOI]
5. Adams LA, "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)[DOI]
6. Belfort R, "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", N Engl J Med, 355, pp.2297~2307 (2006)[DOI]
7. Aithal GP, "Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis", Gastroenterology, 135, pp.1176~1184 (2008)[DOI]
8. Armstrong MJ, "Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebocontrolled phase 2 study", Lancet, 387, pp.679~690 (2016)[DOI]
9. Iwasaki T, "Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus", Hepatogastroenterology, 58, pp.2103~2105 (2011)
10. Yilmaz Y, "Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis", Acta Gastroenterol Belg, 75, pp.240~244 (2012)
11. Cui J, "Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial", J Hepatol, 65, pp.369~376 (2016)[DOI]
12. Joy TR, "Sitagliptin in patients with non-alcoholic steatohepatitis: a randomized, placebo-controlled trial", World J Gastroenterol, 23, pp.141~150 (2017)[DOI]
13. Gkolfakis P, "Gut microbiota and non-alcoholic fatty liver disease", Hepatobiliary Pancreat Dis Int, 14, pp.572~581 (2015)[DOI]
14. Ma YY, "Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis", World J Gastroenterol, 19, pp.6911~6918 (2013)[DOI]
15. Eslamparast T, "Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study", Am J Clin Nutr, 99, pp.535~542 (2014)[DOI]
16. Saba Sayari, "Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 24(3), pp.331~338 (2018), 대한간학회

관련 논문AI추천